This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Alysia Birkholz
CEO Texcell-North America at Texcell


Dr. Alysia Birkholz is the CEO of Texcell's North American division, a prominent contract testing organization specializing in safety testing for adventitious agents in the biopharmaceutical and medical device sectors. In her role, she directs the site, formulates scientific and operational strategies, and collaborates with the global leadership team to advance the mission of safeguarding the future of medicines. Holding a PhD in Biological Sciences from UC San Diego and a BA in Biochemistry and Biology from St. Mary's College of Maryland, Dr. Birkholz brings a strong academic background to her leadership. She has undergone project management training at the Isenberg School of Management, UMass Amherst, and received additional training at the National Institutes of Health (NIH). Dr. Birkholz's diverse career spans roles in career development, professional training, and she is a sought-after guest speaker. Beyond her executive responsibilities, she contributes as a board member for life science education programs and actively mentors biotech startups, showcasing her commitment to advancing the industry and nurturing emerging talent.

Agenda Sessions

  • Securing Advanced Therapies: Viral Safety Measures, Guidelines, and Personal Perspectives